NANJING DORRA PHARMACEUTICAL TECHNOLOGY

CAS No.464-43-7 In-house

Fosfomycin Trometamol, the tromethamine salt of fosfomycin, is a broad-spectrum bactericidal antibiotic. It acts by irreversibly inhibiting the early stage of bacterial cell wall synthesis, effective against both Gram-positive and Gram-negative bacteria, with no cross-resistance to other antibiotics. Chara...

Mirogabalin Besylate is the besylate salt of mirogabalin, a novel gabapentinoid prodrug with excellent solubility and bioavailability. It is a potent and selective ligand for the α2δ-1 subunit of voltage-gated calcium channels. By inhibiting the hyperexcitability of voltage-dependent calcium channels in th...

Venous and arterial returnCosmetic use

SNAC is an absorption enhancer widely used in oral formulations of poorly permeable drugs. It acts by transiently increasing the permeability of the gastrointestinal mucosa, facilitating gastric absorption of macromolecules (e.g., peptides) without damaging the mucosal structure. SNAC has been successfully...

Dorrapharma is engaged in R&D, manufacture and market of intermediates, APls (Active Pharmaceutical Ingredients) and formulations. We own the core technology advantage in the professional area of bromination, enzyme/metal­catalyzed, nitration and hydrogenation, and obtain multiple core patents for invention. We stick to raising the value both for the company and customers, and devote ourselves completely to the technology innovation and brand build and make every effort to foster the core competence for the company with the company mission of a leading pharmaceutical integrated operator with its core competitive advantage in global market.